Lansoprazol Tecnigen

Lansoprazole, the active ingredient in Lansoprazol Tecnigen, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production in adults with acid‑related gastrointestinal conditions.

GNH USA supplies Lansoprazol Tecnigen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazol Tecnigen is a proton pump inhibitor used to manage conditions caused by excess gastric acid.

- Gastro‑esophageal reflux disease (GERD): relief of heartburn and esophageal irritation by decreasing acid exposure. - Duodenal ulcer: promotion of ulcer healing through acid suppression. - Gastric ulcer: reduction of gastric acidity to facilitate mucosal repair. - Helicobacter pylori eradication regimens: enhances the effectiveness of antibiotic therapy by creating a less acidic environment. - Zollinger‑Ellison syndrome: control of hyper‑secretion of gastric acid associated with gastrin‑producing tumors.

Adverse reactions may occur with Lansoprazol Tecnigen. Patients should be aware of both common and serious possibilities.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools, usually transient. - Nausea: occasional upset stomach. - Abdominal pain: discomfort in the upper abdomen. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent diarrhea, abdominal cramping. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Elevated liver enzymes: signs of hepatic stress. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: severe skin reactions. - Interstitial nephritis: kidney inflammation presenting with fever and flank pain.

Before initiating therapy with Lansoprazol Tecnigen, consider the following precautions.

- Assess renal function: dose adjustment may be needed in severe impairment. - Monitor magnesium levels: especially with long‑term use or concomitant diuretics. - Use caution in hepatic impairment: drug metabolism may be altered. - Avoid prolonged use without medical supervision: risk of vitamin B12 deficiency. - Review concomitant medications: potential for reduced efficacy of certain drugs. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Lansoprazol Tecnigen can affect the pharmacokinetics of several medicines. Interactions are grouped by clinical significance.

Major Interactions (Avoid): - Ketoconazole, itraconazole, atazanavir, nelfinavir: reduced absorption due to increased gastric pH. - Clopidogrel: decreased activation leading to reduced antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring closer monitoring. - Digoxin: higher serum concentrations may occur. - Methotrexate (high dose): reduced renal clearance, risk of toxicity. - Phenytoin: decreased serum levels, may reduce seizure control.